Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide, with limited effective therapeutic options currently available. Recent research has highlighted the pivotal role of mitochondrial dysfunction in the pathophysiology of TBI, making mitochondria an attractive target...
Saved in:
Main Authors: | Sidra Tabassum, Silin Wu, Chang-Hun Lee, Bosco Seong Kyu Yang, Aaron M. Gusdon, Huimahn A. Choi, Xuefang S. Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Neurotherapeutics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747924002022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
by: Wang Y, et al.
Published: (2025-02-01) -
Mitochondrial Ribosomal Proteins and Cancer
by: Huiyi Wu, et al.
Published: (2025-01-01) -
PEBP1 amplifies mitochondrial dysfunction-induced integrated stress response
by: Ling Cheng, et al.
Published: (2025-01-01) -
Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease
by: Tian Meng, et al.
Published: (2025-02-01) -
Peripheral mitochondrial transplantation alleviates diabetes-associated cognitive dysfunction by suppressing cuproptosis
by: Juan Hu, et al.
Published: (2025-03-01)